Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

MLSS Milestone Scientific, Inc. Common Stock
$0.28 -4.91% -0.01
Notify me if price changes either direction
Interactive Brokers Logotype

Buy MLSS stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 21.0M
Enterprise value 21.8M
Trailing PE -4.4533332188924
Forward PE -4.6833334
PEG Ratio 0.089066664377848
Enterprise to EBITDA -3.308
Enterprise to revenue 2.442
Price to book MRQ 8.781249
Price to sales TTM 2.474347

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 8.9M
EBITDA -6591487
Diluted EPS TTM -0.08
Total Cash (MRQ) 1.3M
Current ratio (MRQ) 1.611
Operating Cash Flow (TTM) -4201986

MLSS trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent MLSS News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.